Magnacent 75 MG Injection 1

Magnacent 75 MG Injection 1 is used for the following:

• Treatment of female infertility due to anovulation

• Stimulation of ovarian follicle development

• Preparation for assisted reproductive technology procedures

• Support for intrauterine insemination protocols

• Production of multiple mature eggs for fertilisation

• Management of irregular ovulation patterns

• Treatment of male hypogonadotropic hypogonadism

• Stimulation of sperm production in male infertility

• Support for in vitro fertilisation procedures

• Restoration of reproductive function in hormonal deficiencies

Follow these instructions when using Magnacent 75 MG Injection 1:

• This medicine should be administered by a trained doctor or under strict medical supervision.

• The powder must be reconstituted with sterile water or saline solution before use.

• Ensure the solution is clear and free from particles before administration.

• The injection may be given into a muscle or under the skin as directed by your doctor.

• Store unopened vials in a refrigerator between 2°C and 8°C.

• Protect the medicine from light and never freeze it.

• Once reconstituted, use the solution immediately or as advised.

• Follow your doctor's instructions regarding the timing of injections.

Magnacent 75 MG Injection 1 is administered via an intramuscular or subcutaneous route.

Magnacent 75 MG Injection 1 contains human menopausal gonadotrophin also known as menotropin (75 mg), which works on the body in several ways:

• Follicle stimulation: The follicle-stimulating hormone (FSH) component directly stimulates the ovarian follicles to grow and mature, helping in the development of eggs in women.

• Ovulation support: The luteinising hormone (LH) component helps in the final maturation of follicles and plays a crucial role in triggering ovulation when used with other medications.

• Sperm production: In men, the FSH component stimulates the Sertoli cells in the testes, which are responsible for supporting sperm development and production.

• Testosterone production: The LH activity in this medicine stimulates the Leydig cells in male testes, supporting the production of testosterone, an important male hormone.

• Store Magnacent 75 MG Injection 1 in a refrigerator between 2°C and 8°C.

• Keep the vial protected from light in its original packaging.

• Never freeze the medicine as this damages the protein structure.

• After reconstitution, use the solution immediately or as directed by your doctor.

• Discard any unused portion of the reconstituted solution as per local biomedical waste disposal guidelines.

• Keep all medicines out of sight and reach of children.

• Do not use this medicine after the expiry date printed on the vial.

• If you're undergoing fertility treatment with Magnacent 75 MG Injection 1, maintain a balanced diet rich in folate (found in leafy greens and whole grains) to support reproductive health and potential pregnancy.

• Regular, moderate exercise can help improve blood flow to reproductive organs and manage stress levels, which may positively impact fertility outcomes when using gonadotrophin therapy.